Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

International Clinical Psychopharmacology

Volumn 16, Issue 2, 2001, Pages 75-86

  Montgomery, S A ^a,e   Kasper, S ^b   Stein, D J ^c   Hedegaard, K Bang ^d   Lemming, O M ^d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF VIENNA   (Austria)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d H LUNDBECK A S   (Denmark)

^e NONE   (United Kingdom)

Author keywords

Citalopram; Depression; Obsessive compulsive disorder; Selective serotonin reuptake inhibitors

Indexed keywords

CITALOPRAM; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPULSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FATIGUE; FEMALE; FLU LIKE SYNDROME; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; OBSESSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SOMNOLENCE; VERTIGO; XEROSTOMIA;

EID: 0035117059     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200103000-00002     Document Type: Article

References (47)

1. Citalopram treatment of obsessive-compulsive disorder: A pilot study of anti-obsessive efficacy
2. A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder
3. On the information-based measure of covariance complexity and its application to the evaluation of multivariate linear models
4. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder
5. Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression
6. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability
7. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine
8. Treatment of obsessive-compulsive disorder with fluvoxamine: A multicentre, double-blind, placebo-controlled trial
9. Double-blind parallel comparison of three dosages of sertraline and placebo in out-patients with obsessive-compulsive disorder
10. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder
11. Psychobiology of obsessive-compulsive disorder: Anatomical and physiological considerations
12. Methodological issues in the design of clinical studies of new drugs for the treatment of obsessive compulsive disorder
13. Uncomplicated and comorbid obsessive-compulsive disorder in an epidemiologic sample
14. The pharmacology of citalopram
15. Unbalanced repeated-measures with structured covariance matrices
16. The epidemiology of obsessive-compulsive disorder in five US communities
17. Citalopram in the treatment of obsessive-compulsive disorder: An open pilot study
18. The global burden of disease: 1990-2020
19. Clomipramine and exposure for obsessive-compulsive rituals: I
20. Efficacy of fluvoxamine in severe depression
21. Clomipramine in obsessional neurosis: A placebo-controlled trial
22. The place of obsessive compulsive disorder in the diagnostic hierarchy
23. A new depression scale designed to be sensitive to change
24. A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder
25. A 24-week study of 20 mg citalopram: 40 mg citalopram, and placebo in the prevention of relapse of major depression
26. The optimal dosing regimen for citalopram - A meta-analysis of nine placebo-controlled studies
27. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive compulsive disorder: A single-blind study
28. Methods for the evaluation of depressive and manic behavior
29. Citalopram for treatment-resistant obsessive-compulsive disorder
30. Obsessive compulsive disorder: Co-morbid conditions
31. The epidemiology and differential diagnosis of obsessive compulsive disorder
32. The NIMH Epidemiologic Catchment Area Program. Historical context, major objectives, and study population characteristics
33. The measurement of disability
34. Use of the serotonin selective reuptake inhibitor citalopram in obsessive-compulsive disorder
35. Child and adolescent obsessive-compulsive disorder treated with citalopram: Findings from an open trial of 23 cases
36. Clomipramine treatment of obsessive-compulsive disorder
37. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder
38. The cross national epidemiology of obsessive compulsive disorder
39. Low-dose fluoxetine therapy for depression
40. Pharmacotherapy of obsessive-compulsive disorder - Experience with fluoxetine
41. Obsessive-compulsive disorder: Psychobiological approaches to diagnosis, treatment, and pathophysiology
42. An epidemiological study of obsessive-compulsive disorder and related disorders in Israeli adolescents
43. Paroxetine vs clomipramine in the treatment of obsessive-compulsive disorder